DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, směrnice pro lékařskou praxi
PubMed
38852020
DOI
10.1016/j.metabol.2024.155931
PII: S0026-0495(24)00158-6
Knihovny.cz E-zdroje
- MeSH
- diabetes mellitus 2. typu terapie MeSH
- lidé MeSH
- metabolické nemoci * terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- směrnice pro lékařskou praxi MeSH
The spectrum of cardiorenal and metabolic diseases comprises many disorders, including obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), dyslipidemias, hypertension, and associated comorbidities such as pulmonary diseases and metabolism dysfunction-associated steatotic liver disease and metabolism dysfunction-associated steatohepatitis (MASLD and MASH, respectively, formerly known as nonalcoholic fatty liver disease and nonalcoholic steatohepatitis [NAFLD and NASH]). Because cardiorenal and metabolic diseases share pathophysiologic pathways, two or more are often present in the same individual. Findings from recent outcome trials have demonstrated benefits of various treatments across a range of conditions, suggesting a need for practice recommendations that will guide clinicians to better manage complex conditions involving diabetes, cardiorenal, and/or metabolic (DCRM) diseases. To meet this need, we formed an international volunteer task force comprising leading cardiologists, nephrologists, endocrinologists, and primary care physicians to develop the DCRM 2.0 Practice Recommendations, an updated and expanded revision of a previously published multispecialty consensus on the comprehensive management of persons living with DCRM. The recommendations are presented as 22 separate graphics covering the essentials of management to improve general health, control cardiorenal risk factors, and manage cardiorenal and metabolic comorbidities, leading to improved patient outcomes.
AdventHealth Translational Research Institute Orlando FL USA
David Geffen School of Medicine UCLA Los Angeles CA USA
Department of Cardiology National and Kapodistrian University of Athens Athens Greece
Department of Endocrinology Katholieke Universiteit Leuven Leuven Belgium
Department of Internal Medicine Icahn School of Medicine at Mount Sinai NY New York USA
Department of Medicine Baylor College of Medicine Houston TX USA
Department of Medicine Baylor College of Medicine Texas Heart Institute Houston TX USA
Department of Medicine Duke University Medical Center Durham NC USA
Division of Cardiology Duke University School of Medicine Durham NC USA
Division of Cardiology Johns Hopkins University School of Medicine Baltimore MD USA
Division of Endocrinology Metabolism and Nutrition Duke University School of Medicine Durham NC USA
Emory University Atlanta GA USA
Hacettepe University Ankara Turkey
Harvard Medical School Boston University School of Medicine Boston MA USA
Harvard Medical School Brigham and Women's Hospital Boston MA USA
Imperial College London London United Kingdom
Interdisciplinary Research Center Health Science Sant'Anna School of Advanced Studies Pisa Italy
Metabolic Institute of America Tarzana CA USA
Mount Sinai Fuster Heart Hospital Icahn School of Medicine at Mount Sinai NY New York USA
Munich Diabetes Research Group e 5 at Helmholtz Centre Munich Germany
Polyclinique d'Aubervilliers Aubervilliers and Paris Nord University Paris France
Saint Luke's Mid America Heart Institute University of Missouri Kansas City Kansas City MO USA
St Michael's Hospital University of Toronto Toronto Canada
The Frist Clinic Nashville TN USA
Tulane University Health Sciences Center New Orleans LA USA
Université Paris Cité Institut Universitaire de France AP HP Hôpital Bichat Cardiology Paris France
University of Alabama at Birmingham Birmingham AL USA
University of California at Irvine Irvine CA USA
University of California San Diego School of Medicine La Jolla CA USA
University of Chicago Medicine Chicago IL USA
University of Colorado Anschutz Medical Campus Aurora CO USA
University of Copenhagen Copenhagen Denmark
University of Glasgow Glasgow United Kingdom
University of Helsinki Finnish Institute for Health and Welfare Helsinki Finland
University of Leeds Leeds United Kingdom
University of Leicester Leicester United Kingdom
University of Liverpool Liverpool United Kingdom
University of Mississippi Medical Center Jackson MS USA
University of Texas Health Science Center San Antonio TX USA
Citace poskytuje Crossref.org